Will LEADERS-FREE change my practice? A randomised double-blind comparison of the BioFreedom™ drug-coated stent vs. the Gazelle™ bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy

被引:3
|
作者
Stefanini, Giulio G. [1 ]
Behan, Miles [2 ,3 ]
Valgimigli, Marco [4 ]
Oldroyd, Keith G. [5 ]
Leon, Martin B. [6 ]
机构
[1] Humanitas Res Hosp, Cardio Ctr, Via Manzoni 56, I-20089 Rozzano Milan, Italy
[2] Royal Infirm Edinburgh NHS Trust, Edinburgh Heart Ctr, Haddington, E Lothian, Scotland
[3] Roodlands Hosp, Haddington, E Lothian, Scotland
[4] Univ Hosp Bern, Dept Cardiol, Bern, Switzerland
[5] Golden Jubilee Natl Hosp, New West Scotland Reg Heart & Lung Ctr, Glasgow, Lanark, Scotland
[6] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA
关键词
PERCUTANEOUS CORONARY INTERVENTION;
D O I
10.4244/EIJV12I6A129
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:798 / 800
页数:3
相关论文
共 3 条
  • [1] Rationale and design of the LEADERS FREE trial: A randomized double-blind comparison of the BioFreedom drug-coated stent vs the Gazelle bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy
    Urban, Philip
    Abizaid, Alex
    Chevalier, Bernard
    Greene, Samantha
    Meredith, Ian
    Morice, Marie-Claude
    Pocock, Stuart
    AMERICAN HEART JOURNAL, 2013, 165 (05) : 704 - 709
  • [2] Real-world analysis of a Biolimus A9 polymer-free drug-coated stent with very short dual antiplatelet therapy in patients at high bleeding risk
    Chatzantonis, Grigorios
    Chatzantonis, Georgios
    Findeisen, Hannes
    Paul, Matthias
    Samol, Alexander
    Bisdas, Theodosios
    Fischer, Dieter
    HERZ, 2021, 46 (03) : 242 - 249
  • [3] Real-world analysis of a Biolimus A9 polymer-free drug-coated stent with very short dual antiplatelet therapy in patients at high bleeding risk; [Untersuchung eines polymerfreien medikamentenbeschichteten Biolimus-A9-Stents mit sehr kurzer dualer Plättchenhemmung unter Realbedingungen bei Patienten mit hohem Blutungsrisiko]
    Chatzantonis G.
    Chatzantonis G.
    Findeisen H.
    Paul M.
    Samol A.
    Bisdas T.
    Fischer D.
    Herz, 2021, 46 (3) : 242 - 249